ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1
Drug details and screening numbers
Drug Name: Erlotinib
Drug ID: 1
Synonyms:
Brand name: Tarceva
Target: EGFR
Number of cell lines screened: 372
Screening concentration range(s): 0.0078125 to 2 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a306 |
loss_cnaPANCAN2_(STK11) |
1 |
1 |
1 |
Erlotinib |
EGFR |
7 |
364 |
0.693 |
2.48 |
0.84 |
-1.63 |
1.5 * |
1.5 * |
1 * |
2.59e-04 |
7.99e-07 |
1.97e-01 |
14 |
All-tests volcano plot